CorVel Corp

CorVel reported strong fiscal first-quarter results with revenue rising 11% year over year to $260 million and earnings per share increasing 22% to $0.63. New-customer sales jumped more than 60% year over year, and claims volume grew 8%, marking the largest annual quarterly increase since December 2024. The company is expanding AI and automation in claims and clinical workflows, launched Executive Advisory Services and data-driven medical bill repricing, and is advancing CERIS payment-integrity offerings for health plans. CorVel generated $43.1 million in free cash flow, ended the quarter with $256 million in cash and no debt, and repurchased 377,098 shares for $21.8 million. The quarter also marked a leadership transition, with Sarah Scott taking over as president and CEO.

CorVel Corporation has launched CorVel Marketwise Repricing, a market-based medical bill repricing solution designed to enhance cost containment while integrating with existing bill review workflows. The new solution uses real-world reimbursement data and market-based methods to deliver more consistent pricing that reflects local market conditions, capturing additional savings that traditional bill review methods may miss. It is especially useful for out-of-network bills and in states with limited or no fee schedules, and works alongside existing network strategies without adding administrative burden. The announcement was made by CJ Cypcar, Vice President of Network Solutions & Product Integration at CorVel.